FinTrust Capital Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-27,500
| Closed | -$439K | – | 1221 |
|
|
2021
Q4 | $439K | Hold |
27,500
| – | – | 0.11% | 178 |
|
|
2021
Q3 | $442K | Buy |
+27,500
| New | +$442K | 0.12% | 157 |
|
|
2021
Q1 | – | Sell |
-15,150
| Closed | -$266K | – | 1137 |
|
|
2020
Q4 | $266K | Sell |
15,150
-2,000
| -12% | -$35.1K | 0.08% | 198 |
|
|
2020
Q3 | $314 | Sell |
17,150
-550
| -3% | -$10 | 0.06% | 160 |
|
|
2020
Q2 | $317K | Hold |
17,700
| – | – | 0.13% | 149 |
|
|
2020
Q1 | $287K | Buy |
17,700
+2,200
| +14% | +$35.7K | 0.14% | 140 |
|
|
2019
Q4 | $279K | Buy |
+15,500
| New | +$279K | 0.11% | 157 |
|